Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis.

Wang, L; Ko, ER; Gilchrist, JJ; Pittman, KJ; Rautanen, A; Pirinen, M; Thompson, JW; Dubois, LG; Langley, RJ; Jaslow, SL; +15 more... Salinas, RE; Rouse, DC; Moseley, MA; Mwarumba, S; Njuguna, P; Mturi, N; Wellcome Trust Case Control Consortium 2; Kenyan Bacteraemia Study Group; Williams, TN; Scott, JA; Hill, AV; Woods, CW; Ginsburg, GS; Tsalik, EL; Ko, DC; (2017) Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis. Science advances, 3 (3). e1602096. ISSN 2375-2548 DOI: https://doi.org/10.1126/sciadv.1602096

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1126/sciadv.1602096

Abstract

Share

Download

Filename: 1602096.PMC5342653.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar